Possible role of caspase-3 inhibition in cadmium-induced blockage of apoptosis.

Cadmium (Cd) and chromium (Cr) are human carcinogens. Cr(VI) is taken up into cells and reduced by cellular reductants to the potential DNA damaging species Cr(V), (IV), and (III). Reactive oxygen species and carbon-based radicals may also be produced during Cr reduction. We previously found that Cd blocks Cr-induced apoptosis, which could allow a larger proportion of genetically damaged cells to escape and become transformed. This study helped define the mechanisms of Cd-induced suppression of apoptosis. Chinese hamster ovary (CHO K1-BH4) cells were treated with either Cd (5-20 microM), Cr(VI) (350 microM), or Cd (5-20 microM) plus Cr(VI) (350 microM) for 3 h and then cultured in metal-free media for an additional 48 h at which time DNA was extracted or nuclei were examined to determine apoptosis. Cd markedly reduced Cr-induced DNA fragmentation and reduced the number of Cr-induced apoptotic cell nuclei to control levels. Additional study investigated the biokinetics and cellular metabolism of Cr. Cd did not alter the cellular Cr accumulation and there were no differences in the levels of reduced glutathione, a compound possibly important in Cr reduction and reflective of the cellular reducing environment. The antiapoptotic effect of Cd was not due to diminished cellular reduction of Cr(VI) as assessed by electron-spin resonance determination of the levels of Cr(V). Thus, Cd suppression of Cr-induced apoptosis is not based on altered Cr toxicokinetics or metabolism. In addition to Cr, Cd also inhibited apoptosis induced by hygromycin B and actinomycin D. Cd was a very effective inhibitor of caspase-3 activity, a central mediator of apoptosis, with nontoxic levels of Cd resulting in up to approximately 60% inhibition. These results indicate that Cd may have a generalized inhibitory effect on apoptosis, possibly by inhibiting caspase-3. Inhibition of apoptosis by Cd may allow a greater portion of genetically damaged cells to survive, or give selective growth advantages, and has implications as a potential nongenotoxic mechanism of Cd carcinogenesis.

[1]  Gunnar F. Nordberg,et al.  Cadmium and Health: A Toxicological and Epidemiological Appraisal , 2019 .

[2]  M. Waalkes,et al.  Repeated cadmium exposures enhance the malignant progression of ensuing tumors in rats. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  P. Zalewski,et al.  Regulation of caspase activation and apoptosis by cellular zinc fluxes and zinc deprivation: A review , 1999, Immunology and cell biology.

[4]  A. MacKenzie,et al.  The inhibitors of apoptosis (IAPs) and their emerging role in cancer , 1998, Oncogene.

[5]  S. Nakashima,et al.  Increased activity of oleate-dependent type phospholipase D during actinomycin D-induced apoptosis in Jurkat T cells. , 1998, Journal of immunology.

[6]  D. Green.  Apoptotic Pathways The Roads to Ruin , 1998, Cell.

[7]  G. Salvesen,et al.  Properties of the caspases. , 1998, Biochimica et biophysica acta.

[8]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[9]  M. Waalkes,et al.  Cadmium suppresses apoptosis induced by chromium. , 1998, Journal of toxicology and environmental health. Part A.

[10]  M. Waalkes,et al.  Evaluation of the direct genotoxic potential of cadmium in four different rodent cell lines. , 1998, Toxicology.

[11]  A. Dipple,et al.  Effect of cadmium exposure on background and anti-5 methylchrysene-1,2-dihydrodiol 3,4-epoxide-induced mutagenesis in the supF gene of pS189 in human Ad293 cells. , 1998, Chemical research in toxicology.

[12]  J. Orenstein,et al.  Induction of apoptotic cell death by particulate lead chromate: differential effects of vitamins C and E on genotoxicity and survival. , 1997, Toxicology and applied pharmacology.

[13]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[14]  Y. Hannun,et al.  Zinc Is a Potent Inhibitor of the Apoptotic Protease, Caspase-3 , 1997, The Journal of Biological Chemistry.

[15]  N. Bishopric,et al.  Atrial Natriuretic Peptide Induces Apoptosis in Neonatal Rat Cardiac Myocytes* , 1997, The Journal of Biological Chemistry.

[16]  H. Nagase,et al.  Invasive properties of cadmium-resistant human fibrosarcoma HT-1080 cells. , 1997, Cancer biochemistry biophysics.

[17]  A. Hartwig,et al.  Induction and repair inhibition of oxidative DNA damage by nickel(II) and cadmium(II) in mammalian cells. , 1997, Carcinogenesis.

[18]  D. Stearns,et al.  Intermediates produced in the reaction of chromium(VI) with dehydroascorbate cause single-strand breaks in plasmid DNA. , 1997, Chemical Research in Toxicology.

[19]  J. Shaughnessy,et al.  In vitro exposure to cadmium in rat L6 myoblasts can result in both enhancement and suppression of malignant progression in vivo. , 1996, Carcinogenesis.

[20]  P. Branton,et al.  Induction of p53-independent apoptosis by hygromycin B: suppression by Bcl-2 and adenovirus E1B 19-kDa protein. , 1995, Experimental Cell Research.

[21]  P. Giangrande,et al.  Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. , 1995, Biochemistry.

[22]  M. Sugiyama.  Role of paramagnetic chromium in chromium(VI)-induced damage in cultured mammalian cells. , 1994, Environmental health perspectives.

[23]  S. Patierno,et al.  Induction of internucleosomal DNA fragmentation by carcinogenic chromate: relationship to DNA damage, genotoxicity, and inhibition of macromolecular synthesis. , 1994, Environmental health perspectives.

[24]  P. Giangrande,et al.  Chromium(VI) reduction by ascorbate: role of reactive intermediates in DNA damage in vitro. , 1994, Environmental health perspectives.

[25]  J. Orenstein,et al.  Apoptosis is the mode of cell death caused by carcinogenic chromium. , 1994, Toxicology and applied pharmacology.

[26]  D. Stearns,et al.  Reaction of chromium(VI) with ascorbate produces chromium(V), chromium(IV), and carbon-based radicals. , 1994, Chemical research in toxicology.

[27]  N. Ringertz,et al.  Very low cadmium concentrations stimulate DNA synthesis and cell growth. , 1992, Journal of cell science.

[28]  M. Waalkes,et al.  Cadmium-induced DNA strand damage in cultured liver cells: reduction in cadmium genotoxicity following zinc pretreatment. , 1992, Toxicology and applied pharmacology.

[29]  K. Tsuzuki,et al.  Effect of ascorbic acid on DNA damage, cytotoxicity, glutathione reductase, and formation of paramagnetic chromium in Chinese hamster V-79 cells treated with sodium chromate(VI). , 1991, The Journal of biological chemistry.

[30]  S. De Flora,et al.  Genotoxicity of chromium compounds. A review. , 1990, Mutation research.

[31]  A. Standeven,et al.  Chromium(VI) Toxicity: Uptake, Reduction, and DNA Damage , 1989 .

[32]  J. Hamilton,et al.  Molecular basis of hexavalent chromium carcinogenicity: effect on gene expression. , 1989, The Science of the total environment.

[33]  X. Shi,et al.  Chromium (V) and hydroxyl radical formation during the glutathione reductase-catalyzed reduction of chromium (VI). , 1989, Biochemical and biophysical research communications.

[34]  K. Borges,et al.  Role of chromium(V), glutathione thiyl radical and hydroxyl radical intermediates in Chromium(VI)‐induced DNA Damage , 1989 .

[35]  X. Shi,et al.  On the mechanism of the chromate reduction by glutathione: ESR evidence for the glutathionyl radical and an isolable Cr(V) intermediate. , 1988, Biochemical and biophysical research communications.

[36]  S. Patierno,et al.  Characterization of DNA lesions induced by CaCrO4 in synchronous and asynchronous cultured mammalian cells. , 1986, Molecular pharmacology.

[37]  M. Ohsawa,et al.  Participation of active oxygen species in the induction of chromosomal aberrations by cadmium chloride in cultured Chinese hamster cells. , 1985, Mutation research.

[38]  L. Poirier,et al.  In vitro cadmium-DNA interactions: cooperativity of cadmium binding and competitive antagonism by calcium, magnesium, and zinc. , 1984, Toxicology and applied pharmacology.

[39]  L. Loeb,et al.  Infidelity of DNA synthesis in vitro: screening for potential metal mutagens or carcinogens. , 1976, Science.

[40]  R. Hilf,et al.  A fluorometric method for determination of oxidized and reduced glutathione in tissues. , 1976, Analytical biochemistry.

[41]  M. Waalkes.  Quantitation of Metallothionein , 1996 .

[42]  S. Patierno,et al.  Apoptosis: inhibitor or instigator of carcinogenesis? , 1996, Cancer investigation.

[43]  Tsuguyoshi Suzuki,et al.  Toxicology of metals , 1996 .

[44]  M. Waalkes,et al.  Enhanced metallothionein gene expression is associated with protection from cadmium-induced genotoxicity in cultured rat liver cells. , 1994, Journal of toxicology and environmental health.

[45]  M. Sugiyama.  Role of physiological antioxidants in chromium(VI)-induced cellular injury. , 1992, Free radical biology & medicine.

[46]  E. T. Snow.  Metal carcinogenesis: mechanistic implications. , 1992, Pharmacology & therapeutics.

[47]  M. Waalkes,et al.  Toxicological principles of metal carcinogenesis with special emphasis on cadmium. , 1992, Critical reviews in toxicology.